Moreover, the tumor diversity with pigmentation status and tumor location (Supplementary Table S2) provides a comprehensive picture of cutaneous melanoma in a BRAF-driven, MITF-high model (Travnickova et al. 2019). This evidence concerns the gene BRAF and cutaneous melanoma.